PPARGC1A and ovarian carcinoma: Additionally, a decrease in PGC1-α protein expression was observed in PBMCs from participants with early-stage and advanced stage epithelial ovarian cancer (Fig. 2G), indicating that patients with epithelial ovarian cancer exhibited a disruption in mitochondrial biogenesis, possibly leading to the reduction of mitochondrial mass in PBMCs.